“You may choose to look the other way, but you can never say again that you did not know.”
— William Wilberforce
Last week, the U.S. Centers for Disease Control and Prevention (CDC) released data containing reports of health problems, including deaths, following receipt of federally recommended vaccines that have been filed with the federal Vaccine Adverse Event Reporting System (VAERS).1 2 The latest release of VAERS data included descriptions of 438,441 adverse event reports following COVID-19 […]
More than 50 universities across the United States have announced they will require students to present proof of COVID-19 vaccination in order to attend in-person classes or on campus activities this fall.1 Among these institutions of higher learning are Brown University, Cleveland State University, Columbia University, Cornell University, Montclair State University, Princeton University, Rutgers University, […]
Story Highlights Minority populations including Blacks, Hispanics and Native Americans have been disproportionately affected by COVID-19 in the U.S., with evidence indicating they have a higher risk of being infected and/or are at an increased risk of serious disease and death from the infection. Many agencies, public figures and states are advocating that such at-risk […]
Pfizer, Inc. of New York and BioNTech SE of Mainz, Germany have announced that human clinical trials for an experimental COVID-19 vaccine they have co-developed, known as BNT162, have begun in the United States.1 As part of a global clinical development program, the first human subjects in the U.S. Phase I and Phase clinical II […]
Story Highlights Inovio Pharmaceuticals has started Phase 1 testing of its experimental COVID-19 DNA vaccine in healthy volunteers. The U.S. biotech firm has already produced enough of the vaccine to support Phase 1 (immune system reactivity and safety) and Phase 2 (efficacy) testing and plans to have one million doses ready for distribution by the […]
Researchers at the University of Pennsylvania recently reported that they are close to developing a herpes simplex virus 2 (HSV-2) vaccine for humans. HSV-2 primarily causes genital herpes and is contracted through forms of sexual contact with a person who has HSV-2. An estimated 14 percent of Americans between the ages of 15 and 49 […]